1. Home
  2. PDSB vs MYND Comparison

PDSB vs MYND Comparison

Compare PDSB & MYND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDSB
  • MYND
  • Stock Information
  • Founded
  • PDSB 2005
  • MYND 1998
  • Country
  • PDSB United States
  • MYND United States
  • Employees
  • PDSB N/A
  • MYND N/A
  • Industry
  • PDSB Biotechnology: Pharmaceutical Preparations
  • MYND Other Consumer Services
  • Sector
  • PDSB Health Care
  • MYND Real Estate
  • Exchange
  • PDSB Nasdaq
  • MYND Nasdaq
  • Market Cap
  • PDSB 43.1M
  • MYND 38.8M
  • IPO Year
  • PDSB N/A
  • MYND 2017
  • Fundamental
  • Price
  • PDSB $1.25
  • MYND $0.71
  • Analyst Decision
  • PDSB Strong Buy
  • MYND
  • Analyst Count
  • PDSB 3
  • MYND 0
  • Target Price
  • PDSB $10.00
  • MYND N/A
  • AVG Volume (30 Days)
  • PDSB 275.1K
  • MYND 11.2K
  • Earning Date
  • PDSB 05-14-2025
  • MYND 05-06-2025
  • Dividend Yield
  • PDSB N/A
  • MYND N/A
  • EPS Growth
  • PDSB N/A
  • MYND N/A
  • EPS
  • PDSB N/A
  • MYND N/A
  • Revenue
  • PDSB N/A
  • MYND $267,380,999.00
  • Revenue This Year
  • PDSB N/A
  • MYND N/A
  • Revenue Next Year
  • PDSB N/A
  • MYND N/A
  • P/E Ratio
  • PDSB N/A
  • MYND N/A
  • Revenue Growth
  • PDSB N/A
  • MYND N/A
  • 52 Week Low
  • PDSB $0.85
  • MYND $0.61
  • 52 Week High
  • PDSB $4.42
  • MYND $3.89
  • Technical
  • Relative Strength Index (RSI)
  • PDSB 55.58
  • MYND 37.00
  • Support Level
  • PDSB $1.00
  • MYND $0.64
  • Resistance Level
  • PDSB $1.17
  • MYND $0.73
  • Average True Range (ATR)
  • PDSB 0.11
  • MYND 0.08
  • MACD
  • PDSB 0.04
  • MYND 0.01
  • Stochastic Oscillator
  • PDSB 81.61
  • MYND 34.29

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

About MYND Mynd.ai Inc.

Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more.

Share on Social Networks: